Developmental pharmacokinetics and safety of ibuprofen and its enantiomers in the conventional pig as potential pediatric animal model by Millecam, Joske et al.
fphar-10-00505 May 8, 2019 Time: 14:37 # 1
ORIGINAL RESEARCH
published: 09 May 2019
doi: 10.3389/fphar.2019.00505
Edited by:
Roberto Paganelli,
Università degli Studi G. d’Annunzio
Chieti e Pescara, Italy
Reviewed by:
Marzia Del Re,
University of Pisa, Italy
Gabriele Stocco,
University of Trieste, Italy
*Correspondence:
Mathias Devreese
Mathias.Devreese@ugent.be
Specialty section:
This article was submitted to
Translational Pharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 07 February 2019
Accepted: 23 April 2019
Published: 09 May 2019
Citation:
Millecam J, van Bergen T,
Schauvliege S, Antonissen G,
Martens A, Chiers K, Gehring R,
Gasthuys E, Vande Walle J,
Croubels S and Devreese M (2019)
Developmental Pharmacokinetics
and Safety of Ibuprofen and Its
Enantiomers in the Conventional Pig
as Potential Pediatric Animal Model.
Front. Pharmacol. 10:505.
doi: 10.3389/fphar.2019.00505
Developmental Pharmacokinetics
and Safety of Ibuprofen and Its
Enantiomers in the Conventional Pig
as Potential Pediatric Animal Model
Joske Millecam1, Thomas van Bergen2, Stijn Schauvliege2, Gunther Antonissen1,
Ann Martens2, Koen Chiers3, Ronette Gehring4, Elke Gasthuys5, Johan Vande Walle5,
Siska Croubels1 and Mathias Devreese1*
1 Laboratory of Pharmacology and Toxicology, Department of Pharmacology, Toxicology and Biochemistry, Faculty
of Veterinary Medicine, Ghent University, Ghent, Belgium, 2 Department of Surgery and Anesthesiology of Domestic Animals,
Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium, 3 Department of Pathology, Bacteriology and Avian
Diseases, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium, 4 Institute for Risk Assessment, Faculty
of Veterinary Medicine, Utrecht University, Utrecht, Netherlands, 5 Department of Internal Medicine and Pediatrics, Faculty
of Medicine and Health Sciences, Ghent University, Ghent, Belgium
Pediatric drug development, especially in disease areas that only affect children, can
be stimulated by using juvenile animal models not only for general safety studies, but
also to gain knowledge on the pharmacokinetic and pharmacodynamic properties of
the drug. Recently, the conventional growing piglet has been suggested as juvenile
animal model. However, more studies with different classes of drugs are warranted
to make a thorough evaluation whether the juvenile pig might be a suitable preclinical
animal model. Ibuprofen is one of the most widely used non-steroidal anti-inflammatory
drugs in human. The present study determined the PK parameters, gastro-intestinal
and renal safety of 5 mg/kg BW ibuprofen after single intravenous, single oral
and multiple oral administration to each time eight pigs (four males, four females)
aging 1, 4, 8 weeks and 6–7 months. Oral administration was performed via a
gastrostomy button. A jugular catheter was used for intravenous administration and
blood sampling. To assess NSAID induced renal toxicity, renal function was evaluated
using iohexol and p-aminohippuric acid as markers for glomerular filtration rate and
renal plasma flow, respectively. After the trial, necropsy and histology was performed to
evaluate macroscopic and microscopic gastro-intestinal as well as renal lesions. Both
enantiomers, R-ibuprofen and S-ibuprofen, were determined in plasma using an in-
house developed and validated UHPLC-MS/MS method. Pharmacokinetic parameters
were estimated using compartmental analysis. Clearance and volume of distribution
of total ibuprofen and both enantiomers increased with age as was observed in
human. The rate of stereochemical conversion decreased with age. Multiple oral dosing
decreased the absolute oral bioavailability and maximum plasma concentration of
R-ibuprofen and food consumption did not influence drug absorption. Based on the
limited available pediatric literature, the current study might suggest the conventional
pig as suitable animal model to evaluate NSAIDs for pediatric use.
Keywords: ibuprofen, pig, juvenile, enantiomers, pharmacokinetics, animal model
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INTRODUCTION
Since the implementation of the Pediatric Investigation Plan
(PIP) and the Pediatric Safety Plan (PSP) by, respectively, the
European Medicines Agency (EMA) and the Food and Drug
Administration (FDA), the number of clinical trials in children
increased, leading to more and better availability of medicines
for children. However, since the PIP and PSP are driven from
the adult drug development path, little progress has been made
in diseases that only affect children or where the disease shows
biological differences between adults and children (Califf, 2016;
EMA, 2017). The use of juvenile animal models might bridge
that gap. Despite the increase in juvenile animal trials thanks to
the pediatric legislations, almost all juvenile studies mentioned
in the PIPs from 2007 to mid-2017 were general toxicology
studies (Baldrick, 2018). Besides toxicology studies, there is a
need for more pharmacokinetic (PK) and pharmacodynamic
(PD) juvenile studies in the desired age category without any
previous adult human or animal data. This would stimulate
pediatric drug development in diseases that only affect children,
or have a different pathogenesis compared to adults. Selecting the
most appropriate animal species is crucial and the rat (57.5%)
is still the most commonly used juvenile species, followed by
dog (8%), mouse (4.5%), monkey (4%), pig (2%), sheep (1%),
rabbit (1%), and hamster (0.5%). Unfortunately, in 21.5% of
the cases, no species was mentioned (Baldrick, 2018). However,
this does not mean that the rat is the most appropriate animal
model to evaluate pediatric PK/PD and safety characteristics.
The rat is often preferred due to the availability of a large
historical dataset (De Schaepdrijver et al., 2013). Nevertheless,
selection of the animal species should be based on anatomical
and physiological developmental similarities and differences
between the juvenile animal and the pediatric population of
interest, technical requirements, and the properties of the drug
(De Schaepdrijver et al., 2013).
Although the conventional pig is not yet readily used in
preclinical research, PK/PD and safety studies for adults have
already been performed successfully (Swindle et al., 2012; Helke
and Swindle, 2013; Yoshimatsu et al., 2016). Pigs do display
a high level of anatomical and physiological similarities with
human regarding the organs involved in absorption, distribution,
metabolism and excretion (ADME) of drugs. Moreover, growing
piglets display similar maturational processes as seen in children
(Gasthuys et al., 2016, 2017a; Millecam et al., 2018). Recently,
Gasthuys et al. (2018) performed a PK/PD study of desmopressin
in growing piglets and found the piglet to be an appropriate
animal model to predict the clearance of desmopressin in
humans. Nevertheless, other drug classes need to be evaluated to
verify whether the growing piglet might be a good model for the
pediatric population in general.
It has been over 50 years since the discovery of the non-
steroidal anti-inflammatory drug (NSAID) ibuprofen (IBU). Due
to its relatively low risks for gastro-intestinal, hepato-renal, and
other adverse events at over-the-counter doses (<1200 mg/day),
a short elimination half-live compared to other NSAIDs and
thus little propensity to accumulate systemically, IBU is one of
the most used drugs for treatment of acute pain and fever in
humans (Rainsford, 2011). In children, the use of IBU is approved
from 3 months old onwards and is widely used for the same
indications as in adults, namely treatment of inflammation, mild-
to-moderate pain and fever. Safety and efficacy studies are widely
available in the pediatric population, but specific PK studies
are limited, especially regarding the enantiomers of IBU. On
top of that, most studies report general mean values of PK
parameters for the study population as a whole with a broad
age range of included children or they have arbitrary age groups
making it difficult to correctly interpret the data. Moreover,
a detailed and reliable plasma concentration/therapeutic effect
relationship for IBU in the pediatric population is currently
lacking (de Martino et al., 2017). A thorough understanding
of the developmental PK parameters could provide more
information regarding the occurrence of adverse events and
lead to better prediction of efficacy. Especially since S-ibuprofen
(S-IBU) is the pharmacologically active enantiomer and each
enantiomer can lead to different adverse events. In general,
the limited PK data available do suggest similar PK properties
between children younger than 12 years of age and young-to-
middle aged adults (Rainsford, 2009). Rey et al. (1994) found
the plasma concentrations of S-IBU to be lower than those of
R-ibuprofen (R-IBU) in infants (6–18 months of age), indicating
impaired conversion from R- to S-IBU and/or higher clearance of
S-IBU. The clearance rate is believed to be higher in children up to
about 5 years of age and declines in older age groups (Rainsford,
2009). As it is from an ethical point of view difficult to perform
full PK studies in growing children, the conventional piglet might
be a good substitute to gain this developmental PK data.
The aim of the current study was to determine the
PK parameters of IBU after single intravenous, single oral
and multiple oral administrations at therapeutic doses in
conventional pigs of different ages. Next, gastro-intestinal and
renal toxicity was evaluated to assess whether IBU could be
safely administered to pigs as a model for children. All trials
were performed in pigs aging 1, 4, 8 weeks and 6–7 months.
These age groups correspond with the main age categories of the
human pediatric population, namely neonate, infant, child, and
adolescent (Gad, 2015; Gasthuys et al., 2016).
MATERIALS AND METHODS
Animals
The current study was approved by the ethical committee
of the Faculties of Veterinary Medicine and Bioscience
Engineering of Ghent University (EC2016/105). Care and use
of the animals were in full compliance with the national
and European legislation on animal welfare and ethics (Eur-
Lex, 2010; Flemish Government, 2017). Four age categories
were included in the study corresponding with the main age
groups of the human pediatric population, namely neonate,
infant, child, and adolescent (Gad, 2015; Gasthuys et al., 2016).
One-week-old piglets (3.0 ± 0.4 kg BW; Landrace × Large
White × Maximus, RA-SE Genetics, Merkem, Belgium),
4-week-old piglets (7.0 ± 0.8 kg BW; Maximus, RA-SE
Genetics, Bassilly, Belgium), 8-week-old piglets (20.1 ± 3.4 kg
Frontiers in Pharmacology | www.frontiersin.org 2 May 2019 | Volume 10 | Article 505
fphar-10-00505 May 8, 2019 Time: 14:37 # 3
Millecam et al. Pharmacokinetics of Ibuprofen in Pigs
BW; Landrace × Large White, RA-SE Genetics and Convis,
Ettelbruck, Luxembourg) and 6–7-months-old pigs (134± 4.6 kg
BW for males and 142 ± 9.8 kg for females; Landrace × Large
White, RA-SE Genetics and Convis, Ettelbruck, Luxembourg)
were used representing the latter human age groups, respectively.
Each age category consisted of 12 pigs (6 ♂/6 ♀), of which
8 pigs (4 ♂/4 ♀) received ibuprofen and 4 pigs (2 ♂/2 ♀)
served as control. The pigs were randomly allocated to a
treatment group taking an equal distribution of sex in all
groups into account. All male pigs were intact. Since male and
female pigs reach puberty at different ages and the influence
of sex hormones on the PK of ibuprofen was of interest,
the six male pigs were 6 months old, while the six female
pigs were 7 months old (Van den Broeke et al., 2015). All
pigs arrived at least 24 h prior to surgery at the test facility
and were group-housed before surgical procedures in rescue
decks (0.90 m × 1.40 m, Provimi, Rotterdam, Netherlands)
(1-week-old), standard pig stables with partially slatted floors
(2.30 m × 2.40 m) (3.5 and 8 weeks) or sow stables
(0.65 m × 2.20 m) (6–7 months-old). A double lumen catheter
was placed in the jugular vein and a gastrostomy button was
inserted to facilitate blood sampling and multiple oral dosing,
respectively according to Gasthuys et al. (2017b) and Millecam
et al. (unpublished). After surgery, the animals were housed
individually to avoid pen mates biting the catheters. All age
groups had ad libitum access to feed (1 week: RescueMilk R©,
Provimi; 3.5 and 8 weeks: Biggistart Opti R©, Aveve, Leuven,
Belgium; 6–7 months: Optivo Pro R©, Aveve) and water. Natural
light was provided by translucent windows and the stable
temperature was 24.3 ± 2.1◦C during the whole conduct
of the trials. Higher temperatures (30–35◦C) in the rescue
decks were obtained by heating lamps. One day prior to
surgery, a cotton towel was given to the piglets (youngest
three age categories) which was then passed on after surgery
to mimic the smell of the other piglets when they were
singly housed. The 1-week-old pigs could also hear, smell and
see (Plexiglass R©) each other. All stables were enriched with
suspension chains, rubber toys, and balls which were rotated
on a daily basis.
Prior and after surgery, all pigs were weighed on a daily
basis for the whole conduct of the trial (10 days), except
the 6–7 months old pigs who were only weighed the day
of surgery. The pigs were intensively socialized to facilitate
the handling with the catheter and button. Both lumens of
the jugular catheter were flushed at least once daily with a
sterile diluted heparin solution (1-week-old piglets: 0.04% v/v;
4- and 8-week-old piglets: 1% v/v; 6–7-months-old pigs: 2%
v/v). Sealing caps and bandages were changed when needed
and wound healing was monitored. The stomach button was
flushed daily with tap water and the skin surrounding the stoma
was visually inspected on a daily basis. The water and feed
intake, body temperature and interaction with animal caretakers
were monitored twice daily. Temperature was measured via a
LifeChip R© (Allflex Europe SA, Vitré, France) placed in the left
semitendinosus muscle during anesthesia. To evaluate possible
early signs of inflammation, total white blood cell (WBC)
count was performed daily, from the day after surgery till
the end of the trial by taking 1 mL blood via the double
lumen catheter in an K3EDTA collection tube (Vacutest R© Kima,
Arzergrande, Italy). White blood cell count was performed by
Medvet BVBA (Antwerp, Belgium). If the piglets showed more
apathy and had a body temperature ≥ 40◦C, they were treated
with an intramuscular injection of 0.4 mg/kg BW of meloxicam
(Metacam R© 5 mg/mL, Boehringer Ingelheim Vetmedica GmbH,
Ingelheim am Rhein, Germany).
Experimental Design of the Ibuprofen PK
Study
The experimental design was identical for all four age categories
and is graphically shown in Figure 1. The control pigs did
not receive any IBU during the trial, but were sham-treated
with water or NaCl solution for the oral and IV administration,
respectively. After surgery, the pigs had 1 day to recover
before the single dose intravenous PK study of 5 mg/kg BW
IBU (Ibuprofenum, 50/50 ratio R/S-IBU, Fagron, Inc., Meer,
Belgium) was initiated. The drug was dissolved in 0.9% NaCl
(stock solution of 100 mg/mL) and administered IV using the
proximal lumen of the jugular catheter. Next, one wash-out
day was respected before starting the multiple dosing study
with a pediatric IBU suspension (5 mg/kg BW; Ibuprofen
EG R© 40 mg/mL, 50/50 ratio R/S-IBU, Eurogenerics, Brussels,
Belgium). All pigs were fasted overnight before the first oral IBU
administration, except for the 1-week-old piglets. The youngest
age group was deprived of milk only 1 h before administration
due to the risk of hypoglycemia. All pigs had again access to
feed one and a half hour after administration (p.a.). Ibuprofen
was given three times a day for five consecutive days. The
dose interval was 6 h between the morning and the noon dose
and between the noon and the evening dose. After each oral
dose, the gastric tube was flushed with tap water (≥5 mL)
to make sure all IBU entered the stomach. The control pigs
received the same amount of tap water each time. Venous
blood samples for PK analysis were taken on different time
points through the distal lumen of the jugular catheter. The
day of IV administration, blood was taken prior to and 5, 10,
20, 30, 45, 60 min and 1.5, 2, 2.5, 3, 4, 6, 8, and 24 h p.a.
For oral multiple dose PK analysis, blood samples were drawn
each time right before and 30 min p.a., except for the first
(single dose fasted) and 13th (not fasted) oral dose where a full
PK profile was obtained by more frequent sampling (0, 5, 10,
20, 30, 45, 60 min and 1.25, 1.5, 1.75, 2, 2.5, 3, 4, and 6 h
p.a.). All blood samples were transferred into 4 mL K3EDTA
collection tubes, immediately kept on ice and centrifuged for
10 min at 2095 g. Plasma was aliquoted, frozen and stored
at < −15◦C until analysis. Analytical determination of both
IBU enantiomers was performed by an in-house developed
and validated UHPLC-PDA method which is described in the
Supplementary Material. On day 10, all pigs were euthanized
by an IV injection of an overdose of pentobarbital (Sodium
pentobarbital 20% R©, Kela, Hoogstraten, Belgium). When the
double-lumen catheter was no longer functional, euthanasia
was performed by intramuscular injection with a mixture (1:1,
0.22 mL/kg) of xylazine hydrochloride (Xyl-M 2% R©, VMD,
Arendonk, Belgium) and tiletamine-zolazepam (Zoletil 100 R©,
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FIGURE 1 | Graphical overview of the experimental setup. In total, 12 animals (PK: 4 ♂, 4 ♀; control: 2 ♂, 2 ♀) per age category (1, 4, 8 weeks and 6–7 months old)
underwent surgery. The single intravenous dose (IV) ibuprofen was 5 mg/kg BW and the oral dose (PO) was 5 mg/kg three times a day. On day three and day 9, the
glomerular filtration rate (GFR) and estimated renal plasma flow (eRPF) were determined.
Virbac, Netherlands) followed by intracardiac injection of an
overdose of pentobarbital.
Evaluation of Gastro-Intestinal and Renal
Toxicity
Possible physiological changes in kidney function were evaluated
by measuring the glomerular filtration rate (GFR) and estimated
renal plasma flow (eRPF) on the first day of IBU administration
IV and the last day of the oral administration (Figure 1). GFR
was measured through a single dose of 64.7 mg/kg BW of iohexol
(0.1 mL/kg BW, Omnipaque R© 300 mg I/mL, GE Healthcare,
Belgium). Estimated RPF was determined via a single dose of
10 mg/kg BW of p-aminohippuric acid (PAH, stock solution
of 200 mg/mL in 0.9% NaCl solution, Sigma-Aldrich, Overijse,
Belgium). Sampling points overlapped with those of IBU and
were taken right before administration and 5, 10, 30, 60 min
and 2, 3, 6, and 8 h after administration. Determination of
iohexol and PAH in porcine plasma was performed using a
validated UHPLC-MS/MS method (Dhondt et al., 2019). A more
detailed description of this analytical method is given in the
Supplementary Material.
During necropsy, macroscopic lesions were evaluated in the
stomach and kidneys. The stomach was removed and opened
along the greater curvature. After discarding stomach contents
and rinsing the mucosa with water, possible macroscopic gastric
lesions were scored according to the Lanza score (Table 1)
(Lanza et al., 1985). Small samples of duodenum, jejunum, ileum,
pars oesophagea, antrum, fundus, left and right kidney were
fixed in 4% formaldehyde, embedded in paraffin, sectioned at
5 µm and stained with hematoxylin and eosin (HE) according
to standard techniques. The grading scale for histological
examination of the gastro-intestinal samples is given in Table 1
and adapted from Geboes et al. (2000). The samples were blinded
before scoring. Renal samples were microscopically evaluated for
papillary necrosis.
Pharmacokinetic Analysis
All PK analyses were performed in Phoenix version 8.1 (Certara,
Princeton, NJ, United States). Values below the LOQ of
0.25 µg/mL were excluded from the analysis. A 1-compartmental
model was built taking the systemic conversion of R- to
TABLE 1 | Macroscopic and microscopic grading scale for the gastro-intestinal
samples (Lanza et al., 1985; Geboes et al., 2000).
Macroscopic
grade
0 Intact mucosa
1 Redness and hyperemia in the mucosa
2 One or two erosions or hemorrhaging lesions
3 3–10 erosions or hemorrhaging lesions
4 >10 erosions or hemorrhaging lesions
Microscopic
grade
Grade 1 Lymphoid follicles in mucosae and submucosae
Subgrade 1.0 No increase in lymphoid aggregates or follicles
Subgrade 1.1 Moderate increase in lymphoid aggregates (<5)
Subgrade 1.2 Severe increase in lymphoid aggregates (≥5) and/or 1
lymphoid follicle
Subgrade 1.3 ≥2 lymphoid follicles
Grade 2 Chronic inflammatory infiltrate in lamina propria
Subgrade 2.0 No infiltration
Subgrade 2.1 Mild infiltration
Subgrade 2.2 Moderate infiltration
Subgrade 2.3 Severe infiltration
Grade 3 Erosion or ulceration
Subgrade 3.0 No erosion, ulceration, or granulation tissue
Subgrade 3.1 Recovering epithelium + adjacent inflammation
Subgrade 3.2 Probable erosion – focally stripped
Subgrade 3.3 Unequivocal erosion
Subgrade 3.4 Ulcer or granulation tissue
S-ibuprofen (R-to-S-IBU) into account (Figure 2). The dose of
the individual enantiomers was considered half of the racemic
dose of 5 mg/kg BW. Chiral inversion (Cl R to S) was estimated
after IV administration and this value was fixed to estimate
values of the PK parameters after oral administration. The
plasma concentrations of total IBU were calculated from the
sum of R- and S-IBU. The following primary and secondary
PK parameters were calculated for IV and PO administration
for total IBU, R- and S-IBU: clearance (IV only, Cl), apparent
volume of distribution (IV only, Vd), area under the plasma
concentration time curve from time 0 and extrapolated to infinity
(AUC0→∞), maximum plasma concentration for PO (Cmax),
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FIGURE 2 | Representation of the 1-compartmental model for R- and
S-ibuprofen (R-IBU and S-IBU). Cl R to S represents the systemic conversion
of R-ibuprofen to S-ibuprofen.
plasma concentration at time 0 for IV (C0), time to maximum
plasma concentration (Tmax), elimination half-life (T1/2) and
absorption rate constant (ka).
The absolute oral bioavailability (F) was estimated for every
individual pig from the ratio of the areas under the plasma
concentration time curve from time 0 to 3 h (AUC0→3 h) after
PO and IV administration, calculated by non-compartmental
analysis (NCA). The linear up log down trapezoidal method was
used for AUC calculations.
The values of the PK parameters of iohexol and PAH
were estimated using a two- and one-compartmental model,
respectively. The Cl estimated from these models were defined
as GFR and eRPF, respectively.
Allometric relationships were visually evaluated between Cl,
Vd, BW, GFR, and eRPF.
The accumulation ratio after multiple dosing was calculated
using the AUC0→6 h from the first and 13th oral dose
according to Eq. 1.
accumulation ratio = AUC0→6h, dose 13
AUC0→6h, dose 1
(1).
Statistical Analysis
All statistical analyses were performed in RStudio version 1.1.456
(RStudio, Inc., Boston, MA, United States). In order to evaluate
the effect of age and gender on the values of different PK
parameters, a one-way nested ANOVA was performed (p< 0.05).
Normality of the data was checked using Levene’s test. If
the data did not met the criteria of normality (p < 0.01),
a log transformation was performed. Post hoc analysis was
done using Tukey’s HSD (Honestly Significant Difference) test.
Evaluation of the same PK parameter between IV and the first
PO administration and between the first and fifth day of PO
administration was done using a pairwise t-test (p < 0.05).
The significant differences (p < 0.05) between the same PK
parameters for R- and S-IBU were evaluated using a Student’s
t-test for every age group individually.
To evaluate differences in age and treatment group regarding
gastro-intestinal and kidney lesions, a Kruskal–Wallis test was
performed on the sum of the macroscopic and microscopic
scoring per tissue. If the Kruskal–Wallis test was significant
(p < 0.05), a Dunn test (p < 0.025) was performed as post hoc
test. Since two comparisons, namely age and treatment group,
were made in the Dunn test, the significance level of 0.05 was
divided by two, resulting in an alpha of 0.025. GFR and eRPF
were compared between start and end of the trial for every age
group using a pairwise t-test (p < 0.05). Finally, changes in body
temperature and total amount of WBCs were evaluated using
an univariate type III repeated-measures ANOVA. If Mauchly’s
sphericity test was significant (p < 0.05) the Greenhouse–Geisser
correction was applied.
RESULTS
UHPLC-PDA Method for the
Determination of R- and S-Ibuprofen
Supplementary Table S1 summarizes the validation results
obtained for R-IBU and S-IBU in porcine plasma. Linear matrix-
matched calibration curves with a range of 0.25–40 µg/mL for
both enantiomers, were obtained. Good correlation between
analyte concentrations and detected responses was observed for
both enantiomers, with correlation coefficient (r) values ranging
between 0.9949 and 0.9991 and goodness-of-fit coefficient (gof)
values between 3.66 and 9.04%. The acceptance criteria for
within- and between-run accuracy and precision were met for
all drugs at the specified concentration levels (Supplementary
Table S1). The LOQ was 0.25 µg/mL for both enantiomers.
The calculated LOD values, corresponding with a signal/noise
(S/N) ratio of 3, were 0.128 and 0.165 µg/mL for R-IBU and
S-IBU, respectively. No carry-over was present as there was no
analyte detected in the solvent sample injected after the highest
calibrator. No interfering peaks could be detected in any of the
blank samples at the retention time of the drugs, meaning the
specificity of the method was demonstrated.
Animals
All pigs survived the surgery and all double lumen jugular
catheters were functional the day after surgery. Six out of 48
pigs had an obstructed jugular catheter after several days or
accidentally removed the catheter due to scrubbing against the
wall (two control pigs and four pigs in the IBU group, on day
6 or later, except for one 8-week-old control pig who removed
its catheter already 1 day after surgery). If the catheter was
obstructed or removed during the trial, no further blood samples
were taken. Ibuprofen however, was still given via the stomach
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button to evaluate drug safety. The day after surgery, all stomach
buttons, except for one 6-month-old control pig, were functional.
During the trial, one 1-week-old piglet in the IBU group (day 9),
two 8-week-old piglets in the IBU group (days 5 and 8), three
6–7-month-old pigs in the IBU group (days 5, 6, and 9) and
two 6–7-month-old pigs in the control group (days 1 and 2)
had a dysfunctional button after several days due to obstruction
or loss of the button. This also led to exclusion of the animal
from the trial. If the stomach button was obstructed, it was left
in place as the pigs did not seem to experience any nuisance.
If the button was removed, the resulting wound was cleaned,
disinfected and bandaged. Only two 1-week-old and one 4-week-
old piglet, all in the control group, showed more apathy and
had a body temperature ≥ 40◦C. These piglets were successfully
treated with meloxicam.
No significant changes in body temperature were observed
during the trial between treatment and control group or between
the different age groups (Supplementary Figure S1). Similarly,
no significant differences were observed in the WBC count
over time for both control and treatment group. However,
the 1-week-old piglets treated with ibuprofen had a significant
lower amount of leukocytes compared to the control group
(Supplementary Figure S1).
Pharmacokinetics of R-, S-, and Total
Ibuprofen
Total Ibuprofen
The median plasma concentrations [+ standard deviation (SD)]
and the corresponding median fit of total IBU after IV and PO
administration are demonstrated in Figure 3. The PK parameters
are given in Table 2. Both Cl and Vd showed an allometric
relationship with BW with an allometric coefficient of 0.97 and
0.86, respectively (Supplementary Figure S2).
Significant sex differences were only observed at the age of 6–
7 months for ka after the first oral dose, Cmax after 5 days of IBU
dosing and AUC0→3 after IV administration and 5 days of oral
dosing. Age did have a significant effect on all PK parameters.
R- and S-Ibuprofen
The median plasma concentrations (+SD) for R- and S-IBU
after IV and PO administration can be found in Figure 3.
The estimates of the PK parameters are given in Table 2.
Supplementary Figure S2 demonstrates the allometric
relationship between Cl and Vd of R- and S-IBU and BW.
An allometric coefficient of 0.69, 0.79, 1.03, and 0.85 was
estimated for Cl and Vd of R- and S-IBU, respectively.
After IV administration, C0 was higher in the 6–7 months old
pigs compared to the other age groups for both enantiomers. This
might be related to the Vd. Hence, the Vd for R-IBU was the
lowest in the 6–7 months old pigs, but a higher Vd in the 1-week-
old pigs was observed compared to the 4-week-old pigs. Volume
of distribution did not change during the first 8 weeks of life for
S-IBU, but was significantly lower in the 6–7 months old pigs. No
significant differences were observed between the 1-week- and 8-
week-old pigs or the 4-week- and 8-week-old pigs regarding Vd
of R-IBU. Clearance of S-IBU increased with age up until 8 weeks,
after which it decreased. Clearance of R-IBU showed a sinusoidal
course, namely higher in the 1-week- and 8-week-old pigs and
lower in the 4-week- and 6–7-months-old pigs. The half-life of
S-IBU was the highest in the 1-week-old pigs and did not change
in the other age groups. However, T1/2 of R-IBU did show again
the sinusoidal course similar but opposite to Cl of R-IBU, namely
lowest in the 1-week- and 8-week-old pigs, highest in the 4-week-
and 6–7-months old pigs. The AUC of S-IBU was always higher
than that of R-IBU. The 1-week-old piglets had the lowest AUC
for R-IBU and the AUC increased with age. The AUC of S-IBU in
the 8-week-old pigs was lower compared to the other age groups.
After a single oral ibuprofen dose in the fasted state, no
differences with age in T1/2, ka, Tmax, or Cmax were observed
for both enantiomers. Oral bioavailability only changed with
age for R-IBU with the 4-week-old pigs having the lowest F
compared to the other age groups. The AUC of R-IBU stayed
the same during the first 8 weeks of life and was higher in
the 6–7 months old pigs. The AUC of S-IBU on the other
hand, was lower in the 8-week-old pigs compared to the 1-
week- and 6–7-month-old pigs. Regarding significant differences
between both enantiomers after oral dosing, only the 1-week-
old piglets had a significant higher Tmax and Cmax for S-IBU
compared to R-IBU. Cmax of S-IBU at 4 weeks of age was also
significant higher compared to that of R-IBU. And similar to the
IV administration, the AUC of S-IBU was greater than the AUC
of R-IBU in all age groups.
Multiple Oral Dosing of Ibuprofen
After 5 days dosing, few PK parameter estimates changed
compared to the first oral dose (Table 3). Cmax was
lower for R-IBU the last day compared to the first oral
dose and Cmax,R was lower compared to Cmax,S for the
1-week-, 4-week-, and 8-week-old pigs. A lower F for
R-IBU (FR) was also observed. In the 4-week-old pigs,
the AUC of both enantiomers was significantly lower after
5 days of IBU dosing.
The mean ratio of the AUC for R-IBU, S-IBU or total IBU after
the first and last dose, as calculated according to Eq. 1, was lower
than 1 for all four age groups. Results of the accumulation ratio
can be found in Supplementary Table S2.
Safety of Ibuprofen
Ibuprofen was well-tolerated in all pigs in every age group.
During necropsy, no severe lesions could be observed in
the stomach and consequently no significant differences were
observed between the IBU group and the control group.
Microscopic scoring revealed only significant differences between
IBU and control group in the duodenum and jejunum for the
1-week-old pigs and in the antrum for the 4-week-old pigs. No
significant histological changes were observed in the kidney. An
overview of the mean sum of grading scores per tissue and group
is given in Table 3.
The iohexol clearance (GFR) did not show any significant
differences between the two administrations, namely at the start
of the trial and after 5 days of IBU dosing, for all age groups.
However, the eRPF (PAH clearance) was significantly higher at
4 weeks and 6–7 months of age. Boxplots of the results are given
in Supplementary Figure S3.
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FIGURE 3 | Median (+ standard deviation) plasma concentrations of total ibuprofen (top), R-ibuprofen (middle) and S-ibuprofen (bottom) after intravenous (left) and
oral (right) administration of racemic ibuprofen (5 mg/kg BW) to each time 8 (4 ♂, 4 ♀) pigs aging 1 week (blue cross), 4 weeks (orange square), 8 weeks (gray
triangle) and 6–7 months (yellow dot). The lines are the corresponding median model fits using the PK model.
The eRPF showed a good correlation with GFR
which is reflected in almost identical allometric
coefficients when Cl is plotted against GFR or eRPF
(Supplementary Figure S2).
DISCUSSION
The current study aimed to evaluate developmental changes in
pharmacokinetic parameters of R-, S-, and total ibuprofen
in growing conventional pigs after single intravenous,
single oral and multiple oral administration, as well as the
drug’s safety profile.
Developmental Pharmacokinetics of
Total Ibuprofen in Pigs
The absorption of IBU in the fasted state was significantly faster
in the 1-week-old and 6–7 months old pigs compared to the other
two age groups. In the 6–7 months old pigs, this is probably due
to the greater contact surface area. In neonatal pigs however, the
gastric pH is higher compared to older pigs. A higher pH would
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TABLE 3 | The mean and standard deviation (SD) of the sum of macroscopic and histological scores per tissue for the ibuprofen (n = 8 per age group) and control group
(n = 4 per age group) for the 1-week-, 4-week-, 8-week- and 6–7-months-old pigs.
Duodenum Jejunum Ileum Pars oesophagea Antrum Fundus Macroscopic score
1-week-old pigs
Ibuprofen 1.38 (0.52)∗ 3.63 (2.88)∗ 5.13 (0.99) 1.75 (2.19) 2.13 (1.13) 4.0 (1.77) 0.25 (0.46)
Control 4 (1.63)∗ 1.25 (0.50)∗ 5.25 (0.50) 1.75 (1.50) 3.50 (1.73) 5.0 (1.41) 0 (0)
4-week-old pigs
Ibuprofen 3.50 (2.22) 3.63 (0) 3.13 (0) 3.75 (2.22) 2.75 (0.50)∗ 0.75 (1.91) 2.13 (0.58)
Control 4.75 (2.22) 3.0 (0) 3.0 (0) 1.75 (2.22) 5.25 (0.50)∗ 1.50 (1.91) 1.50 (0.58)
8-week-old pigs
Ibuprofen 3.75 (0.71) 4.88 (1.64) 6 (0) 2.13 (1.55) 2.38 (1.69) 2.75 (1.16) 2.25 (1.04)
Control 4.0 (0.82) 4.25 (2.06) 6 (0) 1.25 (0.50) 2.75 (0.96) 2.75 (1.71) 3.0 (0.82)
6–7-months-old pigs
Ibuprofen 3.25 (1.16) 3.38 (1.69) 6.38 (0.74) 4.50 (3.66) 2.88 (2.42) 2.13 (1.96) 1.75 (0.71)
Control 4.0 (0.82) 3.25 (1.89) 6.25 (0.50) 3.75 (3.77) 3.75 (1.71) 2.25 (1.89) 1.25 (0.50)
Significant differences were determined with a Kruskal–Wallis test. Dunn‘s test was used for post hoc analysis. ∗Significant difference between ibuprofen and control
group within that age group (p < 0.025).
normally lead to less passive absorption in combination with a
weak acid drug such as ibuprofen (pKa = 5.3) (Walthall et al.,
2005). Nevertheless, since the 1-week-old piglets drank milk 1.5 h
before administration, it is possible that the pH was lower leading
to a faster absorption. The maturational changes in PK estimates
will be discussed by means of the IV data. The Cl, when expressed
per kg BW, increased with age up until 8 weeks of age, after
which it decreased again (6–7 months old). Since IBU is known
to be primarily metabolized in the liver, the maturation of CYP
enzymes will be a defining factor for Cl as IBU is extensively
metabolized by CYP2C8 and CYP2C9 in human (Rainsford,
2009). The homologs porcine CYP2C enzymes did increase with
age in conventional pigs from a neonatal age till 8 weeks of
age. Moreover, the amount of CYP2C35 in liver microsomes
was lower in the 6–7 months old pigs compared to the 8-
week-old pigs. This strengthens the suggestion that CYP2C35
might be involved in the biotransformation of IBU (Millecam
et al., 2018). The Cl of IBU will also be influenced by the liver-
to-body weight ratio (Rainsford, 2009). Millecam et al. (2018)
suggested a log linear relationship between liver and body weight
in conventional pigs from birth till puberty, with a maximum
BW of 124 kg. In contrast, Hu (2015) observed a decreasing
liver-to-body weight ratio after 5 weeks of age in Camborough-
29 pigs. Since the oldest pigs in the current study all weighed
more than 124 kg and the Cl is lower compared to the younger
pigs, it is believed that the liver to body weight ratio would be
much lower compared to these younger pigs. Hence, the observed
non-linear relationship between non-weight-normalized Cl and
weight do support these findings (Supplementary Figure S2). In
human, the liver-to-body weight ratio also follows a non-linear
curve with aging (‘t Jong, 2014). At last, both GFR and eRPF
were significantly lower in the 6–7 months old pigs compared to
the 8-week-old pigs. Since the metabolites of IBU are primarily
renally excreted, these low renal physiological parameters will
contribute to the lower Cl observed in these oldest pigs. The
observed relationship between Cl and GFR and eRPF is then also
almost linear (Supplementary Figure S2).
The Vd, expressed per kg BW, showed a sinusoidal course with
age, with the highest observed Vd in the 1-week- and 8-week-old
pigs. These differences are probably due to the combination of
maturation of the drug binding protein, albumin, and changes
in the body composition. Neonatal pigs still have immature
albumin levels which reach adult values around 1 year of age
(Gasthuys et al., 2016). Low amounts of albumin leads thus
to a higher free fraction of IBU and a higher Vd. The body
composition in pigs changes during development. Warnants et al.
(2006) demonstrated that 4–10-week-old pigs had 10% fat, while
6-month-old pigs had > 20% fat. Although the log octanol-
water partition coefficient is 3.97 for ibuprofen, a decreased
Vd in obese adults compared to adults with a normal BW
for IBU was observed and attributed to the body composition
(Abernethy and Greenblatt, 1985). A lower Vd in 6–7 months
old pigs with a high fat content is thus considered similar to
human. Nevertheless, non-weight-normalized Vd did show an
allometric relationship with weight (Supplementary Figure S2).
The observed developmental differences in Cl and Vd, which
are not linearly related to BW, emphasize the importance of
evaluating non-weight-normalized PK parameters.
Only limited sex differences in the 6–7-month-old pigs were
noticed. After the first oral dose, ka of total IBU was significantly
higher in the females compared to the males. A clear hypothesis
for this observation cannot be put forward. Next to that, the
AUCIV,0→3 of total IBU was significantly higher in the males
compared to the females. This might be due to the observed
similar differences in AUCIV,0→3 for R-IBU. A higher AUC could
suggest a slower R-to-S conversion. Nevertheless, no significant
sex differences in Cl or Cl R to S were observed.
Several studies in children demonstrated a relationship
between Cl and Vd and age (Supplementary Table S3). While
Brown et al. (1992) observed a decreasing Cl and Vd with age,
Har-Even et al. (2014) and Khalil et al. (2017) observed an
increasing Cl and Vd with age/weight. The Cl in children was
10.3, 19.5, 32.8, and 81.3 mL/min for children aged 1, 6 months –
2, 2–6, and 6–16 years, respectively (Khalil et al., 2017). This is
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similar to the increasing whole body Cl observed in the current
study, namely 6.8, 25.9, 111.1, and 307.5 mL/min for the 1-
week-, 4-week-, 8-week-, and 6–7-month-old pigs, respectively.
Similarly, Vd in the pediatric age groups as mentioned above
increased from 1053.7 mL in the 1-month-old infants to
10314.2 mL in children aged 6–16 years. In pigs, Vd increased as
well, namely 907.3 mL in the 1-week-old pigs toward 19527.1 mL
in the 6–7-months old pigs. This limited available pediatric data
might suggest that the juvenile pig could be a suitable animal
model for the pediatric population. However, further research
is required to evaluate allometric scaling or other in silico tools.
Moreover, more thorough PK studies are warranted where all
pediatric data are described in the most comprehensive way, since
often only the mean parameters of a wide age range are provided.
Enantiomeric Pharmacokinetics of
Ibuprofen in the Growing Piglet
The developmental PK of R- and S-IBU showed great differences
most likely attributed to their enantioselective behavior. Both
enantiomers were rapidly absorbed in all age groups, but the
Cmax,S and Tmax,S were always higher/later compared to R-IBU.
This is probably due to the systemic stereochemical conversion
of R-IBU to S-IBU. Pigs are able to perform chiral inversion,
as was shown after administration of the pure R-enantiomer of
ketoprofen (Neirinckx et al., 2011b). The rate of stereochemical
conversion of R-IBU decreased with age and was the highest in
the 1-week-old piglets (Table 2). Since no urine was collected, it
was not possible to determine the fraction of the dose converted.
In human adults, the conversion rate was estimated to be 0.53–
0.82 mL/min/kg with a total fraction of 0.48 to 0.68 of the
dose being converted (Rudy et al., 1991; Tan et al., 2003). In
the pediatric population, very limited data is available regarding
the conversion of IBU. Gregoire et al. (2008) estimated that
17% of R-IBU was converted to S-IBU in premature newborn
infants. Rey et al. (1994) found the plasma concentrations of
S-IBU always to be smaller than those of R-IBU probably due
to impaired conversion or higher S-IBU clearance. It should be
noted however that these infants were treated with IBU during
surgery recovery, meaning that the after-effects of the anesthesia
could possibly have affected the PK of IBU. Generation of more
pediatric data is warranted to obtain a full developmental profile
of the stereochemical conversion of R- to S-IBU since the results
of Rey et al. (1994) are currently generalized for the complete
pediatric population although it only covers infants (Rey et al.,
1994; Rainsford, 2009).
No significant differences could be found between R-IBU
and S-IBU regarding F. While FS did not change with age,
FR was significantly lower at 4 weeks of age compared to
the 1-week-old piglets. This might be an indication of pre-
systemic conversion. Nevertheless, since no differences in PK
parameters between IV and PO administration at 4 weeks
of age were observed, it is highly doubtful if pre-systemic
conversion does actually occur. The 4-week-old pigs were weaned
at arrival at the test facility and this could have had an
influence on FR. It is known that weaning activates several
immune and inflammatory responses, which are likely a cause
of small intestine atrophy (Bomba et al., 2014; Cao et al., 2018).
Consequently, this might lead to enantioselective absorption
with a preference for the S-enantiomer or faster pre-systemic
elimination of R-IBU. Enantioselective absorption, however, has
not yet been reported in literature.
The Cl of R- and S-IBU changed differently during the first
4 weeks of life. While Cl of R-IBU (ClR) decreased, Cl of S-IBU
(ClS) increased during these first 4 weeks. These developmental
changes in porcine Cl are similar to pediatric data generated by
Dong et al. (2000), where a decreasing ClR with age and a higher
weight normalized ClR in children (2–13 years) compared to
adults was found. The S-enantiomer showed no correlation with
age in these children.
Both enantiomers had the lowest Vd at 6–7 months which
could be attributed to the body composition as discussed above.
After IV administration, VR was higher compared to VS in
the 1-week-old piglets (329.9 versus 248.5 mL/kg respectively).
Neonatal pigs still have immature albumin concentrations,
making them more subject to differences in enantioselective
protein binding. In human, the protein binding is competitive
and enantioselective, with a higher affinity of R-IBU for albumin
compared to S-IBU. This leads to a higher free fraction of S-IBU
and consequently a higher VS in human. The results in the
neonatal pigs however, suggest otherwise, namely higher albumin
affinity for S-IBU (Hao et al., 2005). This hypothesis should be
verified with protein binding experiments using both racemic
ibuprofen and the individual enantiomers.
The enantiomeric differences in T1/2 were also comparable
to human. In premature new-born infants, T1/2,S was found to
be longer than T1/2,R (2,058 vs. 498 min on post-natal day 1,
Supplementary Table S3), which was also observed in the 1-
week-old piglets (99.2 vs. 22.6 min) (Gregoire et al., 2008). The
differences in porcine T1/2 became smaller with aging, as was also
observed in human by Kelley et al. (1992), Dong et al. (2000), and
Tan et al. (2003). Rey et al. (1994) on the other hand, found no
enantiomeric differences in T1/2.
While the PK of the IBU enantiomers in the growing pig
does show some similarities with the available human data,
thorough comparison is impossible due to the lack of extensive
PK studies evaluating both enantiomers in the complete pediatric
population. Further research is warranted.
Multiple Oral Dosing
Consecutive oral dosing for 5 days did alter the enantioselective
PK characteristics in growing piglets although no accumulation
was observed. In children aged 4–11 years, also no IBU
accumulation occurred after five oral doses of an IBU-
pseudoephedrine suspension every 6 h. However, the PK
characteristics were only determined after the fifth dose (Gelotte
et al., 2010). In humans, the absorption of IBU tablets is
believed to be determined by gastric emptying and the gastro-
intestinal transit time (Neirinckx et al., 2011a; Koenigsknecht
et al., 2017). The current study used a suspension which was
apparently not influenced by the fed state, as demonstrated by
the absent differences in Tmax or ka between the first and last
oral administration of the multiple oral dosing study. However,
Cmax,R and FR were decreased, except for the 1-week-old pigs
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(FR) and 6–7 months old pigs (Cmax,R), which could mean that
pre-systemic conversion or elimination occurred upon multiple
dosing. Unfortunately, no extensive similar human PK data are
available. Most human PK trials are single dose only or the
PK studies were only performed at the start or end of the trial
when multiple dosing was done, but not on both occasions as in
the current study.
Safety Profile of Ibuprofen
Since only the duodenum and jejunum of the 1-week-old IBU
group showed a higher inflammatory response, while the other
significant higher responses were observed in the control group,
IBU was considered to be safe to administer to pigs from 1-
week-old till 6–7-months of age. This is consistent with the
low incidence of adverse events observed in children (Rainsford,
2009; de Martino et al., 2017; Ziesenitz et al., 2017). Regarding
renal safety, elevated eRPF was observed in the 4-week- and 6–
7-months-old pigs, but no differences in GFR were observed.
This is in contrast with the results from Junot et al. (2017)
where both a decreased GFR and renal blood flow were observed
after administration of ketoprofen to pigs weighing 25–32 kg.
It would be expected that NSAIDs such as IBU, decrease GFR
and eRPF due to their inhibitory effect on the formation of
vasodilatating prostaglandins (Kim, 2008). However, since pigs
are able to acetylate PAH, this route of elimination needs to
be taken into account when determining the true RPF (Troncy
et al., 1997). The eRPF determined in the current study represents
both renal and metabolic clearance. The increased eRPF could
be attributed to an increased acetylation capacity instead of
an IBU-related vasodilatation which would be contradictory.
In conclusion, 5 days dosing of IBU did not alter the renal
function of the piglets.
CONCLUSION
The developmental and enantioselective PK of IBU in the
growing piglet was demonstrated. Multiple oral dosing did affect
some PK parameters, decreased the bioavailability of R-IBU and
was shown to be safe. Age did affect the rate of stereochemical
conversion. The limited human PK data available showed a
similar increase in Cl and Vd of total ibuprofen as observed in
the current study, suggesting the conventional pig as a suitable
animal model to evaluate ibuprofen and possibly other NSAIDs.
Nevertheless, more comprehensive pediatric data regarding the
IBU enantiomers is warranted.
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